I 

110TH CONGRESS 

1ST SESSION H. R. 1072 

To improve the health of women through the establishment of Offices of 

Women’s Health within the Department of Health and Human Services. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 15, 2007 

Mrs. MALONEY of New York (for herself, Ms. PRYCE of Ohio, Mr. VAN

HOLLEN, Mrs. CAPPS, Ms. DELAURO, Ms. NORTON, Mr. CROWLEY, Mrs. 

LOWEY, Mr. MARSHALL, Ms. SLAUGHTER, Ms. SUTTON, and Mr. 

FATTAH) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To improve the health of women through the establishment 

of Offices of Women’s Health within the Department 

of Health and Human Services. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Women’s Health Office 

5 Act of 2007’’. 

mstockstill on PROD1PC66 with BILLS

2 

•HR 1072 IH

1 SEC. 2. HEALTH AND HUMAN SERVICES OFFICE ON WOM2 EN’S HEALTH. 

3 (a) ESTABLISHMENT.—Part A of title II of the Pub4 lic Health Service Act (42 U.S.C. 202 et seq.) is amended 

5 by adding at the end the following: 

6 ‘‘SEC. 229. HEALTH AND HUMAN SERVICES OFFICE ON 

7 WOMEN’S HEALTH. 

8 ‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab9 lished within the Office of the Secretary, an Office on 

10 Women’s Health (referred to in this section as the ‘Of11 fice’). The Office shall be headed by a Deputy Assistant 

12 Secretary for Women’s Health who may report to the Sec13 retary. 

14 ‘‘(b) DUTIES.—The Secretary, acting through the Of15 fice, with respect to the health concerns of women, shall— 

16 ‘‘(1) establish short-range and long-range goals 

17 and objectives within the Department of Health and 

18 Human Services and, as relevant and appropriate, 

19 coordinate with other appropriate offices on activi20 ties within the Department that relate to disease 

21 prevention, health promotion, service delivery, re22 search, and public and health care professional edu23 cation, for issues of particular concern to women; 

24 ‘‘(2) provide expert advice and consultation to 

25 the Secretary concerning scientific, legal, ethical, 

26 and policy issues relating to women’s health; 

mstockstill on PROD1PC66 with BILLS

3 

•HR 1072 IH

1 ‘‘(3) monitor the Department of Health and 

2 Human Services’ offices, agencies, and regional ac3 tivities regarding women’s health and stimulate ac4 tivities and facilitate coordination of such depart5 mental and agency offices on women’s health; 

6 ‘‘(4) establish a Department of Health and 

7 Human Services Coordinating Committee on Wom8 en’s Health, which shall be chaired by the Deputy 

9 Assistant Secretary for Women’s Health and com10 posed of senior level representatives from each of the 

11 agencies and offices of the Department of Health 

12 and Human Services; 

13 ‘‘(5) establish a National Women’s Health In14 formation Center to— 

15 ‘‘(A) facilitate the exchange of information 

16 regarding matters relating to health informa17 tion, health promotion, preventive health serv18 ices, research advances, and education in the 

19 appropriate use of health care; 

20 ‘‘(B) facilitate access to such information; 

21 ‘‘(C) assist in the analysis of issues and 

22 problems relating to the matters described in 

23 this paragraph; and 

24 ‘‘(D) provide technical assistance with re25 spect to the exchange of information (including 

mstockstill on PROD1PC66 with BILLS

4 

•HR 1072 IH

1 facilitating the development of materials for 

2 such technical assistance); 

3 ‘‘(6) coordinate efforts to promote women’s 

4 health programs and policies with the private sector; 

5 and 

6 ‘‘(7) through publications and any other means 

7 appropriate, provide for the exchange of information 

8 between the Office and recipients of grants, con9 tracts, and agreements under subsection (c), and be10 tween the Office and health professionals and the 

11 general public. 

12 ‘‘(c) GRANTS AND CONTRACTS REGARDING DU13 TIES.— 

14 ‘‘(1) AUTHORITY.—In carrying out subsection 

15 (b), the Secretary may make grants to, and enter 

16 into cooperative agreements, contracts, and inter17 agency agreements with, public and private entities, 

18 agencies, and organizations. 

19 ‘‘(2) EVALUATION AND DISSEMINATION.—The 

20 Secretary shall directly or through contracts with 

21 public and private entities, agencies, and organiza22 tions, provide for evaluations of projects carried out 

23 with financial assistance provided under paragraph 

24 (1) and for the dissemination of information devel25 oped as a result of such projects. 

mstockstill on PROD1PC66 with BILLS

5 

•HR 1072 IH

1 ‘‘(d) REPORTS.—Not later than 1 year after the date 

2 of enactment of this section, and every second year there3 after, the Secretary shall prepare and submit to the appro4 priate committees of Congress a report describing the ac5 tivities carried out under this section during the period 

6 for which the report is being prepared. 

7 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 

8 purpose of carrying out this section, there are authorized 

9 to be appropriated such sums as may be necessary for 

10 each of the fiscal years 2008 through 2012. 

11 ‘‘(f) LIMITATION ON TERMINATION OF OFFICE.— 

12 Notwithstanding any other provision of law, the Office es13 tablished under this section may not be terminated, reor14 ganized, or have any of its powers or duties transferred 

15 unless such termination, reorganization, or transfer is ap16 proved by Congress through the adoption of a concurrent 

17 resolution of approval.’’. 

18 (b) TRANSFER OF FUNCTIONS.—There are trans19 ferred to the Office on Women’s Health (established under 

20 section 229 of the Public Health Service Act, as added 

21 by this section), all functions exercised by the Office on 

22 Women’s Health of the Public Health Service prior to the 

23 date of enactment of this section, including all personnel 

24 and compensation authority, all delegation and assign25 ment authority, and all remaining appropriations. All ormstockstill on PROD1PC66 with BILLS

6 

•HR 1072 IH

1 ders, determinations, rules, regulations, permits, agree2 ments, grants, contracts, certificates, licenses, registra3 tions, privileges, and other administrative actions that— 

4 (1) have been issued, made, granted, or allowed 

5 to become effective by the President, any Federal 

6 agency or official thereof, or by a court of competent 

7 jurisdiction, in the performance of functions trans8 ferred under this subsection; and 

9 (2) are in effect at the time this section takes 

10 effect, or were final before the date of enactment of 

11 this section and are to become effective on or after 

12 such date; 

13 shall continue in effect according to their terms until 

14 modified, terminated, superseded, set aside, or revoked in 

15 accordance with law by the President, the Secretary, or 

16 other authorized official, a court of competent jurisdiction, 

17 or by operation of law. 

18 SEC. 3. CENTERS FOR DISEASE CONTROL AND PREVEN19 TION OFFICE OF WOMEN’S HEALTH. 

20 Part A of title III of the Public Health Service Act 

21 (42 U.S.C. 241 et seq.) is amended by adding at the end 

22 the following: 

mstockstill on PROD1PC66 with BILLS

7 

•HR 1072 IH

1 ‘‘SEC. 310A. CENTERS FOR DISEASE CONTROL AND PREVEN2 TION OFFICE OF WOMEN’S HEALTH. 

3 ‘‘(a) ESTABLISHMENT.—There is established within 

4 the Office of the Director of the Centers for Disease Con5 trol and Prevention, an office to be known as the Office 

6 of Women’s Health (referred to in this section as the ‘Of7 fice’). The Office shall be headed by a director who shall 

8 be appointed by the Director of such Centers. 

9 ‘‘(b) PURPOSE.—The Director of the Office shall— 

10 ‘‘(1) report to the Director of the Centers for 

11 Disease Control and Prevention on the current level 

12 of the Centers’ activity regarding women’s health 

13 conditions across, where appropriate, age, biological, 

14 and sociocultural contexts, in all aspects of the Cen15 ters’ work, including prevention programs, public 

16 and professional education, services, and treatment; 

17 ‘‘(2) establish short-range and long-range goals 

18 and objectives within the Centers for women’s health 

19 and, as relevant and appropriate, coordinate with 

20 other appropriate offices on activities within the 

21 Centers that relate to prevention, research, edu22 cation and training, service delivery, and policy de23 velopment, for issues of particular concern to 

24 women; 

25 ‘‘(3) identify projects in women’s health that 

26 should be conducted or supported by the Centers; 

mstockstill on PROD1PC66 with BILLS

8 

•HR 1072 IH

1 ‘‘(4) consult with health professionals, non2 governmental organizations, consumer organizations, 

3 women’s health professionals, and other individuals 

4 and groups, as appropriate, on the policy of the Cen5 ters with regard to women; and 

6 ‘‘(5) serve as a member of the Department of 

7 Health and Human Services Coordinating Com8 mittee on Women’s Health (established under sec9 tion 229(b)(4)). 

10 ‘‘(c) COORDINATING COMMITTEE.— 

11 ‘‘(1) ESTABLISHMENT.—In carrying out sub12 section (b), the Director of the Office shall establish 

13 a committee to be known as the Coordinating Com14 mittee on Women’s Health (referred to in this sub15 section as the ‘Coordinating Committee’). 

16 ‘‘(2) COMPOSITION.—The Coordinating Com17 mittee shall be composed of the directors of the na18 tional centers and other appropriate officials of the 

19 Centers for Disease Control and Prevention. 

20 ‘‘(3) CHAIRPERSON.—The Director of the Of21 fice shall serve as the Chairperson of the Coordi22 nating Committee. 

23 ‘‘(4) DUTIES.—With respect to women’s health, 

24 the Coordinating Committee shall assist the Director 

25 of the Office in— 

mstockstill on PROD1PC66 with BILLS

9 

•HR 1072 IH

1 ‘‘(A) identifying the need for programs and 

2 activities that focus on women’s health; 

3 ‘‘(B) identifying needs regarding the co4 ordination of activities, including intramural 

5 and extramural multidisciplinary activities; and 

6 ‘‘(C) making recommendations to the Di7 rector of the Centers for Disease Control and 

8 Prevention concerning findings made under 

9 subparagraphs (A) and (B). 

10 ‘‘(d) REPORTS.—Not later than 1 year after the date 

11 of enactment of this section, and every second year there12 after, the Director of the Office shall prepare and submit 

13 to the appropriate committees of Congress a report de14 scribing the activities carried out under this section during 

15 the period for which the report is being prepared. 

16 ‘‘(e) DEFINITION.—As used in this section, the term 

17 ‘women’s health conditions’, with respect to women of all 

18 age, ethnic, and racial groups, means diseases, disorders, 

19 and conditions— 

20 ‘‘(1) unique to, significantly more serious for, 

21 or significantly more prevalent in women; and 

22 ‘‘(2) for which the factors of medical risk or 

23 type of medical intervention are different for women, 

24 or for which there is reasonable evidence that indimstockstill on PROD1PC66 with BILLS

10 

•HR 1072 IH

1 cates that such factors or types may be different for 

2 women. 

3 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—For the 

4 purpose of carrying out this section, there are authorized 

5 to be appropriated such sums as may be necessary for 

6 each of the fiscal years 2008 through 2012. 

7 ‘‘(g) LIMITATION ON TERMINATION OF OFFICE.— 

8 Notwithstanding any other provision of law, the Office es9 tablished under this section may not be terminated, reor10 ganized, or have any of its powers or duties transferred 

11 unless such termination, reorganization, or transfer is ap12 proved by Congress through the adoption of a concurrent 

13 resolution of approval.’’. 

14 SEC. 4. OFFICE OF WOMEN’S HEALTH RESEARCH. 

15 Section 486(a) of the Public Health Service Act (42 

16 U.S.C. 287d(a)) is amended by inserting ‘‘and who shall 

17 report directly to the Director’’ before the period at the 

18 end thereof . 

19 SEC. 5. SUBSTANCE ABUSE AND MENTAL HEALTH SERV20 ICES ADMINISTRATION. 

21 Section 501(f) of the Public Health Service Act (42 

22 U.S.C. 290aa(f)) is amended— 

23 (1) in paragraph (1), by inserting ‘‘who shall 

24 report directly to the Administrator’’ before the pe25 riod; 

mstockstill on PROD1PC66 with BILLS

11 

•HR 1072 IH

1 (2) by redesignating paragraph (4) as para2 graph (5); and 

3 (3) by inserting after paragraph (3), the fol4 lowing: 

5 ‘‘(4) OFFICE.—Nothing in this subsection shall 

6 be construed to preclude the Secretary from estab7 lishing within the Substance Abuse and Mental 

8 Health Administration an Office of Women’s 

9 Health.’’. 

10 SEC. 6. AGENCY FOR HEALTHCARE RESEARCH AND QUAL11 ITY ACTIVITIES REGARDING WOMEN’S 

12 HEALTH. 

13 Part C of title IX of the Public Health Service Act 

14 (42 U.S.C. 299c et seq.) is amended— 

15 (1) by redesignating sections 937 and 938 as 

16 sections 938 and 939, respectively; 

17 (2) by inserting after section 936 the following: 

18 ‘‘SEC. 937. ACTIVITIES REGARDING WOMEN’S HEALTH. 

19 ‘‘(a) ESTABLISHMENT.—There is established within 

20 the Office of the Director, an Office of Women’s Health 

21 and Gender-Based Research (referred to in this section 

22 as the ‘Office’). The Office shall be headed by a director 

23 who shall be appointed by the Director of Healthcare and 

24 Research Quality. 

mstockstill on PROD1PC66 with BILLS

12 

•HR 1072 IH

1 ‘‘(b) PURPOSE.—The official designated under sub2 section (a) shall— 

3 ‘‘(1) report to the Director on the current 

4 Agency level of activity regarding women’s health, 

5 across, where appropriate, age, biological, and 

6 sociocultural contexts, in all aspects of Agency work, 

7 including the development of evidence reports and 

8 clinical practice protocols and the conduct of re9 search into patient outcomes, delivery of health care 

10 services, quality of care, and access to health care; 

11 ‘‘(2) establish short-range and long-range goals 

12 and objectives within the Agency for research impor13 tant to women’s health and, as relevant and appro14 priate, coordinate with other appropriate offices on 

15 activities within the Agency that relate to health 

16 services and medical effectiveness research, for 

17 issues of particular concern to women; 

18 ‘‘(3) identify projects in women’s health that 

19 should be conducted or supported by the Agency; 

20 ‘‘(4) consult with health professionals, non21 governmental organizations, consumer organizations, 

22 women’s health professionals, and other individuals 

23 and groups, as appropriate, on Agency policy with 

24 regard to women; and 

mstockstill on PROD1PC66 with BILLS

13 

•HR 1072 IH

1 ‘‘(5) serve as a member of the Department of 

2 Health and Human Services Coordinating Com3 mittee on Women’s Health (established under sec4 tion 229(b)(4)). 

5 ‘‘(c) COORDINATING COMMITTEE.— 

6 ‘‘(1) ESTABLISHMENT.—In carrying out sub7 section (b), the official designated under subsection 

8 (a) shall establish a committee to be known as the 

9 Coordinating Committee on Women’s Health (re10 ferred to in this subsection as the ‘Coordinating 

11 Committee’). 

12 ‘‘(2) COMPOSITION.—The Coordinating Com13 mittee shall be composed of the official designated 

14 under subsection (a) and the directors of the centers 

15 and offices of the Agency. 

16 ‘‘(3) CHAIRPERSON.—The official designated 

17 under subsection (a) shall serve as the Chairperson 

18 of the Coordinating Committee. 

19 ‘‘(4) DUTIES.—With respect to research on 

20 women’s health, the Coordinating Committee shall 

21 assist the official designated under subsection (a) 

22 in— 

23 ‘‘(A) identifying the need for such re24 search, and making an estimate each fiscal year 

mstockstill on PROD1PC66 with BILLS

14 

•HR 1072 IH

1 of the funds needed to adequately support the 

2 research; 

3 ‘‘(B) identifying needs regarding the co4 ordination of research activities, including in5 tramural and extramural multidisciplinary ac6 tivities; and 

7 ‘‘(C) making recommendations to the Di8 rector of the Agency concerning findings made 

9 under subparagraphs (A) and (B). 

10 ‘‘(d) REPORTS.—Not later than 1 year after the date 

11 of enactment of this section, and every second year there12 after, the official designated under subsection (a) shall 

13 prepare and submit to the appropriate committees of Con14 gress a report describing the activities carried out under 

15 this section during the period for which the report is being 

16 prepared. 

17 ‘‘(e) LIMITATION ON TERMINATION OF OFFICE.— 

18 Notwithstanding any other provision of law, the Office es19 tablished under this section may not be terminated, reor20 ganized, or have any of its powers or duties transferred 

21 unless such termination, reorganization, or transfer is ap22 proved by Congress through the adoption of a concurrent 

23 resolution of approval.’’; and 

24 (3) by adding at the end of section 938 (as re25 designated by paragraph (1)) the following: 

mstockstill on PROD1PC66 with BILLS

15 

•HR 1072 IH

1 ‘‘(f) WOMEN’S HEALTH.—For the purpose of car2 rying out section 937 regarding women’s health, there are 

3 authorized to be appropriated such sums as may be nec4 essary for each of the fiscal years 2008 through 2012.’’. 

5 SEC. 7. HEALTH RESOURCES AND SERVICES ADMINISTRA6 TION OFFICE OF WOMEN’S HEALTH. 

7 Title VII of the Social Security Act (42 U.S.C. 901 

8 et seq.) is amended by adding at the end the following: 

9 ‘‘SEC. 713. OFFICE OF WOMEN’S HEALTH. 

10 ‘‘(a) ESTABLISHMENT.—The Secretary shall estab11 lish within the Office of the Administrator of the Health 

12 Resources and Services Administration, an office to be 

13 known as the Office of Women’s Health. The Office shall 

14 be headed by a director who shall be appointed by the Ad15 ministrator. 

16 ‘‘(b) PURPOSE.—The Director of the Office shall— 

17 ‘‘(1) report to the Administrator on the current 

18 Administration level of activity regarding women’s 

19 health across, where appropriate, age, biological, and 

20 sociocultural contexts; 

21 ‘‘(2) establish short-range and long-range goals 

22 and objectives within the Health Resources and 

23 Services Administration for women’s health and, as 

24 relevant and appropriate, coordinate with other ap25 propriate offices on activities within the Administramstockstill on PROD1PC66 with BILLS

16 

•HR 1072 IH

1 tion that relate to health care provider training, 

2 health service delivery, research, and demonstration 

3 projects, for issues of particular concern to women; 

4 ‘‘(3) identify projects in women’s health that 

5 should be conducted or supported by the bureaus of 

6 the Administration; 

7 ‘‘(4) consult with health professionals, non8 governmental organizations, consumer organizations, 

9 women’s health professionals, and other individuals 

10 and groups, as appropriate, on Administration policy 

11 with regard to women; and 

12 ‘‘(5) serve as a member of the Department of 

13 Health and Human Services Coordinating Com14 mittee on Women’s Health (established under sec15 tion 229(b)(4) of the Public Health Service Act). 

16 ‘‘(c) COORDINATING COMMITTEE.— 

17 ‘‘(1) ESTABLISHMENT.—In carrying out sub18 section (b), the Director of the Office shall establish 

19 a committee to be known as the Coordinating Com20 mittee on Women’s Health (referred to in this sub21 section as the ‘Coordinating Committee’). 

22 ‘‘(2) COMPOSITION.—The Coordinating Com23 mittee shall be composed of the directors of the bu24 reaus of the Administration. 

mstockstill on PROD1PC66 with BILLS

17 

•HR 1072 IH

1 ‘‘(3) CHAIRPERSON.—The Director of the Of2 fice shall serve as the Chairperson of the Coordi3 nating Committee. 

4 ‘‘(4) DUTIES.—With respect to women’s health, 

5 the Coordinating Committee shall assist the Director 

6 of the Office in— 

7 ‘‘(A) identifying the need for programs and 

8 activities that focus on women’s health; 

9 ‘‘(B) identifying needs regarding the co10 ordination of activities, including intramural 

11 and extramural multidisciplinary activities; and 

12 ‘‘(C) making recommendations to the Ad13 ministrator concerning findings made under 

14 subparagraphs (A) and (B). 

15 ‘‘(d) REPORTS.—Not later than 1 year after the date 

16 of enactment of this section, and every second year there17 after, the Director of the Office shall prepare and submit 

18 to the appropriate committees of Congress a report de19 scribing the activities carried out under this section during 

20 the period for which the report is being prepared. 

21 ‘‘(e) DEFINITIONS.—For purposes of this section: 

22 ‘‘(1) ADMINISTRATION.—The term ‘Administra23 tion’ means the Health Resources and Services Ad24 ministration. 

mstockstill on PROD1PC66 with BILLS

18 

•HR 1072 IH

1 ‘‘(2) ADMINISTRATOR.—The term ‘Adminis2 trator’ means the Administrator of the Health Re3 sources and Services Administration. 

4 ‘‘(3) OFFICE.—The term ‘Office’ means the Of5 fice of Women’s Health established under this sec6 tion in the Administration. 

7 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—For the 

8 purpose of carrying out this section, there are authorized 

9 to be appropriated such sums as may be necessary for 

10 each of the fiscal years 2008 through 2012. 

11 ‘‘(g) LIMITATION ON TERMINATION OF OFFICE.— 

12 Notwithstanding any other provision of law, the Office es13 tablished under this section may not be terminated, reor14 ganized, or have any of its powers or duties transferred 

15 unless such termination, reorganization, or transfer is ap16 proved by Congress through the adoption of a concurrent 

17 resolution of approval.’’. 

18 SEC. 8. FOOD AND DRUG ADMINISTRATION OFFICE OF 

19 WOMEN’S HEALTH. 

20 Chapter IX of the Federal Food, Drug, and Cosmetic 

21 Act (21 U.S.C. 391 et seq.) is amended by adding at the 

22 end the following: 

23 ‘‘SEC. 910. OFFICE OF WOMEN’S HEALTH. 

24 ‘‘(a) ESTABLISHMENT.—There is established within 

25 the Office of the Commissioner, an office to be known as 

mstockstill on PROD1PC66 with BILLS

19 

•HR 1072 IH

1 the Office of Women’s Health (referred to in this section 

2 as the ‘Office’). The Office shall be headed by a director 

3 who shall be appointed by the Commissioner of Food and 

4 Drugs. 

5 ‘‘(b) PURPOSE.—The Director of the Office shall— 

6 ‘‘(1) report to the Commissioner of Food and 

7 Drugs on current Food and Drug Administration 

8 (referred to in this section as the ‘Administration’) 

9 levels of activity regarding women’s participation in 

10 clinical trials and the analysis of data by sex in the 

11 testing of drugs, medical devices, and biological 

12 products across, where appropriate, age, biological, 

13 and sociocultural contexts; 

14 ‘‘(2) establish short-range and long-range goals 

15 and objectives within the Administration for issues 

16 of particular concern to women’s health within the 

17 jurisdiction of the Administration, including, where 

18 relevant and appropriate, adequate inclusion of 

19 women and analysis of data by sex in Administration 

20 protocols and policies; 

21 ‘‘(3) provide information to women and health 

22 care providers on those areas in which differences 

23 between men and women exist; 

24 ‘‘(4) consult with pharmaceutical, biologics, and 

25 device manufacturers, health professionals with exmstockstill on PROD1PC66 with BILLS

20 

•HR 1072 IH

1 pertise in women’s issues, consumer organizations, 

2 and women’s health professionals on Administration 

3 policy with regard to women; 

4 ‘‘(5) make annual estimates of funds needed to 

5 monitor clinical trials and analysis of data by sex in 

6 accordance with needs that are identified; and 

7 ‘‘(6) serve as a member of the Department of 

8 Health and Human Services Coordinating Com9 mittee on Women’s Health (established under sec10 tion 229(b)(4) of the Public Health Service Act). 

11 ‘‘(c) COORDINATING COMMITTEE.— 

12 ‘‘(1) ESTABLISHMENT.—In carrying out sub13 section (b), the Director of the Office shall establish 

14 a committee to be known as the Coordinating Com15 mittee on Women’s Health (referred to in this sub16 section as the ‘Coordinating Committee’). 

17 ‘‘(2) COMPOSITION.—The Coordinating Com18 mittee shall be composed of the directors of the cen19 ters of the Administration. 

20 ‘‘(3) CHAIRPERSON.—The Director of the Of21 fice shall serve as the Chairperson of the Coordi22 nating Committee. 

23 ‘‘(4) DUTIES.—With respect to women’s health, 

24 the Coordinating Committee shall assist the Director 

25 of the Office in— 

mstockstill on PROD1PC66 with BILLS

21 

•HR 1072 IH

1 ‘‘(A) identifying whether there is a need 

2 for further studies and, if so, developing strate3 gies to foster such studies; 

4 ‘‘(B) identifying issues in specific areas of 

5 women’s health that fall within the mission of 

6 the Administration; 

7 ‘‘(C) identifying whether any need exists 

8 for the coordination of Administration activi9 ties, including internal and external activities; 

10 ‘‘(D) maintaining the Administration’s 

11 focus in areas of importance to women; 

12 ‘‘(E) supporting the development of meth13 odologies to determine how to obtain data spe14 cific to women (including data relating to the 

15 age of women and the membership of women in 

16 ethnic or racial groups); and 

17 ‘‘(F) supporting the development and ex18 pansion of clinical trials of treatments and 

19 therapies for which obtaining such data has 

20 been determined to be an appropriate function. 

21 ‘‘(d) REPORTS.—Not later than 1 year after the date 

22 of enactment of this section, and every second year there23 after, the Director of the Office shall prepare and submit 

24 to the appropriate committees of Congress a report demstockstill on PROD1PC66 with BILLS

22 

•HR 1072 IH

1 scribing the activities carried out under this section during 

2 the period for which the report is being prepared. 

3 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 

4 purpose of carrying out this section, there are authorized 

5 to be appropriated such sums as may be necessary for 

6 each of the fiscal years 2008 through 2012. 

7 ‘‘(f) LIMITATION ON TERMINATION OF OFFICE.— 

8 Notwithstanding any other provision of law, the Office es9 tablished under this section may not be terminated, reor10 ganized, or have any of its powers or duties transferred 

11 unless such termination, reorganization, or transfer is ap12 proved by Congress through the adoption of a concurrent 

13 resolution of approval.’’. 

14 SEC. 9. NO NEW REGULATORY AUTHORITY. 

15 Nothing in this Act and the amendments made by 

16 this Act may be construed as establishing regulatory au17 thority or modifying any existing regulatory authority. 

18 SEC. 10. LIMITATION ON TERMINATION. 

19 Notwithstanding any other provision of law, a Fed20 eral office of women’s health (including the Office of Re21 search on Women’s Health of the National Institutes of 

22 Health) or Federal appointive position with primary re23 sponsibility over women’s health issues (including the As24 sociate Administrator for Women’s Services under the 

25 Substance Abuse and Mental Health Services Administramstockstill on PROD1PC66 with BILLS

23 

•HR 1072 IH

1 tion) that is in existence on the date of enactment of this 

2 Act shall not be terminated, reorganized, or have any of 

3 its powers or duties transferred unless such termination, 

4 reorganization, or transfer is approved by Congress 

5 through the adoption of a concurrent resolution of ap6 proval. 

Æ 

mstockstill on PROD1PC66 with BILLS